Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DexCom Hospital Study-CGM Directed Insulin Delivery

NCT05504785 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT05504785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05504785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DexCom Hospital Study-CGM Directed Insulin Delivery
Lead sponsor
Thomas Jefferson University
Phase
Not applicable
Overall status
Terminated
Start date
August 1, 2020
Completion date
August 1, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip osteoarthritis, knee osteoarthritis, type 2 diabetes